OncoMatch

OncoMatch/Clinical Trials/NCT05439005

Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.

Is NCT05439005 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies Dexmedetomidine for breast cancer.

Phase 3RecruitingInstitut CurieNCT05439005Data as of Jun 2026Location: France

Treatment: DexmedetomidineThis study will compare morphine consumption during the first 48 hours postoperatively between the OFA group and the CA control group.

Check if I qualify

Extracted eligibility criteria

Treatments studied

Other

Dexmedetomidine

Cancer type

Breast Carcinoma

Demographics

Female only

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Frequently asked questions

Is NCT05439005 currently recruiting?

Yes, this trial is currently recruiting patients.

Is this trial open to male patients?

No. This trial enrolls female patients only.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify